You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 1 Issues Articles
Popular Type 1 Issues Articles
Highly Recommended Type 1 Issues Articles
Send a link to this page to your friends and colleagues.
German researchers who compared insulin lispro (Humalog) and insulin aspart (NovoLog) report that the two insulins are equally effective in controlling after-meal blood glucose in people with type 1 diabetes.
In a study funded by Novo Nordisk—the maker of NovoLog—24 people with type 1 diabetes were observed in a single-center, randomized, double-blind trial. The participants were given Humalog or NovoLog injections immediately before a standard mixed meal.
Blood-glucose excursions 4 hours and 6 hours after the meal were equivalent, as were maximum blood-glucose excursions.
—Diabetes Care, November 2002
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.